FDA Drug Application (202458) for FLUVASTATIN SODIUM by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number202458
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 80MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameFLUVASTATIN SODIUM
Active IngredientFLUVASTATIN SODIUM

Active IngredientCount
List of drugs with Active Ingredient FLUVASTATIN SODIUM3


Back to FDA Applications sponsored by MYLAN PHARMS INC